Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| KEK-ZH-Nr: 2013-0519 | Other Identifier | Zurich Ethics Committee |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to find the most agreeable and in the long term most efficient treatment for epistaxis.
In the general population epistaxis occurs quite frequently. Approximately 60% of persons will be affected once in their lifetime, and 6% thereof will seek medical advice. Thereby anterior and posterior epistaxis are discerned. Anterior epistaxis is usually located at the Locus Kisselbachii, while posterior bleeds are found further back in the nose. There, most bleeds will originate from the A. sphenopalatina or the A. ethmoidalis.
Different treatment modalities exist. Anterior epistaxis are usually easier to treat than posterior ones. The aim of this study is to find the most efficient treatment. This involves the assessment of long term results and potential sequelae. Existing data will be complemented with information about recurrences and complications. The question is: Which treatment method leads to the least numbers of recurrences in the long term with the fewest long term sequelae?
Secondly, the most agreeable, least painful treatment method is to be identified. Therefore we will send out questionnaires to patients that were treated between March 29, 2007 and April 1st, 2008 at the Zurich University Hospital.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Electric coagulation | Patients with anterior epistaxis, treated with electric coagulation | ||
| Chemical coagulation | Patients with anterior epistaxis, treated with chemical coagulation | ||
| Outpatient tamponade | Patients with posterior epistaxis, treated with tamponade as an outpatient | ||
| Inpatient tamponade | Patients with posterior epistaxis, treated with tamponade and kept in the hospital. | ||
| Surgery | Patients with posterior epistaxis, treated with surgery as inpatients | ||
| Foley balloon catheter | Patients with posterior epistaxis, treated as inpatients with Foley balloon catheter | ||
| Combined treatment | Patients with posterior epistaxis, treated as inpatients with a combination of methods |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients without recurrence | Up to 8 years post-treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Discomfort caused by treatment | Up to 1 day post-treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Number of complications due to treatment | Up to 8 years post-treatment | |
| Sequelae due to treatment | Up to 8 years post-treatment |
Inclusion Criteria:
All patients treated during the study period with known address and who did not decease in the meantime.
Exclusion Criteria:
Insufficiently filled out questionnaires; Obvious lack of ability to remember (as tested by control questions); Known mental disability
Not provided
Not provided
All patients treated between March 29, 2007 and April 1st, 2008 for epistaxis at the ENT Dept. of the Zurich University Hospital
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael Soyka, Dr.med. | Zurich University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Zurich University Hospital | Zurich | Canton of Zurich | 8091 | Switzerland |
Not provided
| ID | Term |
|---|---|
| D004844 | Epistaxis |
| ID | Term |
|---|---|
| D009668 | Nose Diseases |
| D012140 | Respiratory Tract Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D006470 | Hemorrhage |
Not provided
Not provided
Not provided
Not provided
Not provided
| D010335 |
| Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |